{ "@context": "https://schema.org/", "@type": "ScholarlyArticle", "url": "https://newcells-biotech.cargodev.co.uk/resources/posters/utilization-of-high-content-imaging-for-the-study-of-lung-fibrosis/", "name": "Utilization of High Content Imaging for the Study of Lung Fibrosis", "author": { "@type": "Organization", "name": "NewCells Biotech" }, "publisher": { "@type": "Organization", "name": "NewCells Biotech" }, "description": "A poster presenting research on the use of high content imaging techniques to study lung fibrosis.", "keywords": [ "lung fibrosis", "high content imaging", "biomedical research", "respiratory disease" ], "genre": "Research Poster", "datePublished": "2024", "about": { "@type": "MedicalCondition", "name": "Lung Fibrosis" }, "workExample": { "@type": "ImageObject", "name": "High Content Imaging of Lung Fibrosis" }, "thumbnailUrl": "https://newcells-biotech.cargodev.co.uk/path-to-poster-thumbnail.jpg" }

Home › Resources › Posters

News

18th October, 2024

How is AI Impacting drug discovery?

How do you envision the role of AI evolving in the drug discovery process over the next decade? Colin Brown: “The role of AI in the discovery…

17th October, 2024

Transforming Drug Development with 3D Retina Models

Newcells Biotech Limited, a team of internationally recognised experts in the building and application of complex models of human tissues for drug discovery, was awarded £1m to deliver their…

24th September, 2024

Scientific discussion with our CSO: what is next for in vitro models?

What are the latest trends for new in vitro models? There are really two trends. The first one, of course, is to make more physiologically…

20th September, 2024

Ask an expert: What are the latest trends in in vitro models?

What are the latest trends for new in vitro models? In the field, we have been talking about very complex models, so-called organs on chip,…

9th September, 2024

Newcells Biotech launches Lung Ciliary Beat Frequency assay to enhance safety and efficacy profiling in preclinical drug development

Newcastle, UK, 09 September 2024: Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction…

28th August, 2024

Latest advances in In Vitro models

What are the latest trends for new in vitro models ? I think the latest trend that we are seeing is in terms of the ability of…

Press Release: Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes

1st August, 2024

Press Release: Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes

1st August, 2024

Press Release: Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes

Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes,…

Rhys and collin at JSOT 2024

12th July, 2024

The Intensity of Innovation: Insights from the Japanese Society of Toxicology Conference

A Unique Exhibition-Poster Integration One striking feature of JSOT is how they seamlessly integrate exhibitions with poster sessions. Exhibitors and poster presenters are…

Press Release: Newcells Biotech appoints Emile Shaffu as Director of Sales

Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes,…

28th June, 2024

Newsletter June 2024

How does Newcells works with their clients? Listen to our CEO, Dr Mike Nicholds explaining. Webinar on demand: Moving compounds to IND using predictive retinal models. Our panel of experts…

11th June, 2024

Press Release : Newcells Biotech strengthens executive and US team with key appointments

Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial appointments also announced…

6th March, 2024

Biotech firm raises £2.3m for lab models that help avoid animal testing

The Newcastle-based company has secured funding from existing investors including the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures, Mercia’s own funds…